5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sun Pharmaceutical Industries Ltd.

•
sunpharma.comBSE: 524715NSE: SUNPHARMA
Market Cap₹ 4,41,958 Cr.
Current Price
High / Low₹ 2,047 / 1,548
Stock P/E147.6
Book Value₹ 98
Price to Book18.85
Dividend Yield0.87 %
ROCE13.3 %
ROE11.3 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 25.5% CAGR over last 5 years
  • Latest quarter profit grew 48.0% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.08x)
  • Company has a consistent dividend-paying track record
  • Company generates healthy free cash flow

CONS

  • Recent results are weak - TTM profit is down 47.4% versus prior year
  • A large part of profit comes from other income (47.8% of PBT)
  • Working capital days have increased from 9 to 179 days
  • Stock is trading at 18.8x its book value
  • Operating margins have contracted to 23.1% from 32.4%
  • Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY PHARMANIFTYLARGEMIDCAP250NIFTY100 LOWVOL30NIFTY100 EQL WGT
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.BIOCON390.95128.6363712.890.13136.8053.364336.0010.893.2619.54
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
4,3835,0204,9045,5374,4105,1185,9747,1015,5674,5115,6514,8875,741
3,5173,7193,8663,7463,7373,9194,4764,1203,9003,8464,0923,5954,363
Operating Profit8661,3001,0371,7916731,1991,4982,9811,6666651,5591,2921,378
OPM %19.76%25.90%21.15%32.35%15.26%23.42%25.07%41.98%29.93%14.74%27.59%26.44%24.00%
14116159119832246913265548463172
Interest158194215218216259231232223248244217278
Depreciation415393400393370297303305299336339326308
Profit before Tax3909077511,4022588711,2402,6541,1856721,0978491,486
Tax %2.37%1.97%4.01%38.11%7.79%3.73%6.76%23.05%36.40%16.01%35.70%28.30%24.98%
Net Profit3818897218682388381,1562,0427545647056091,115
1.603.703.003.601.003.504.808.503.102.402.902.504.60

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
7,6848,98210,30312,53214,11615,58620,81220,27522,97720,75520,791
7,7458,1288,5629,82011,85912,91714,39014,77516,39515,96815,897
Operating Profit-618551,7422,7122,2572,6696,4235,5006,5834,7874,894
OPM %-0.79%9.52%16.90%21.64%15.99%17.12%30.86%27.13%28.65%23.06%23.54%
690301721,511103-624-2,6083346341,267873
Interest224388541408268388472784954948988
Depreciation4224875535621,2361,3501,6011,6011,2871,3121,309
Profit before Tax-172807193,2538563071,7413,4504,9763,7944,104
Tax %-35.95%-9.06%-13.50%1.29%1.54%132.58%2.89%17.15%15.03%30.86%27.06%
Net Profit-233068173,211842-1001,6912,8584,2282,6232,994
EPS-0.101.303.4013.383.50-0.407.0011.9117.6210.93—
Dividend Payout %-3676.47%157.00%80.80%29.89%213.61%-2399.81%163.20%113.33%90.80%146.33%—

COMPOUNDED SALES GROWTH

10 Years:
10%
5 Years:
8%
3 Years:
0%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
26%
3 Years:
16%

STOCK PRICE CAGR

10 Years:
9%
5 Years:
19%
3 Years:
17%
1 Year:
14%

RETURN ON EQUITY

10 Years:
7%
5 Years:
10%
3 Years:
14%
Last Year:
11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jul 7

₹ 5

Rs.5.0000 per share(500%)Final Dividend

2026

Feb 5

₹ 11

Interim Dividend

2025

Jul 7

₹ 5.50

Rs.5.5000 per share(550%)Final Dividend

2025

Feb 6

₹ 10.50

Interim Dividend

2024

Jul 12

₹ 5

Rs.5.0000 per share(500%)Final Dividend

2024

Feb 9

₹ 8.50

Interim Dividend

2023

Jul 28

₹ 4

Rs.4.0000 per share(400%)Final Dividend

2023

Feb 8

₹ 7.50

Interim Dividend

2022

Aug 19

₹ 3

Rs.3.0000 per share(300%)Final Dividend

2022

Feb 9

₹ 7

Rs.7.0000 per share(700%)Interim Dividend

2021

Aug 23

₹ 2

Rs.2.0000 per share(200%)Final Dividend

2021

Feb 9

₹ 5.50

Rs.5.5000 per share(550%)Interim Dividend

2020

Feb 17

₹ 3

Rs.3.0000 per share(300%)Interim Dividend

2018

Sep 17

₹ 2

Rs.2.0000 per share(200%)Dividend

2017

Sep 18

₹ 3.50

Rs.3.5000 per share(350%)Dividend

2016

Sep 8

₹ 1

Rs.1.0000 per share(100%)Dividend

2015

Oct 21

₹ 3

Rs.3.0000 per share(300%)Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital240240240240240240240240240240
20,77022,08322,60424,15626,69924,34823,50823,45423,66022,131
4,8156,7795,8705,9077,8735,6778,67312,71612,48513,935
Trade Payables2,0732,5662,1552,1294,0292,7103,1262,6203,4703,533
6,3125,4627,1846,3155,2778,0825,7772,9555,4716,170
Total Liabilities34,21037,13038,05238,74744,11841,05841,32441,98545,32746,010
4,0394,6454,9785,2299,6699,7138,7127,7377,3727,613
Capital Work in Progress1,055830456384459359329388708652
19,33318,35517,90417,36215,53715,54912,61312,43012,41012,952
2,3082,1362,7932,6343,4233,4043,9893,4243,9344,302
00000008,83411,70210,166
Cash & Bank170155341655361535421338911437
7,30411,00911,58012,48414,66811,49815,2608,8348,2899,887
Total Assets34,21037,13038,05238,74744,11841,05841,32441,98545,32746,010

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
-837-8801,2801,643-1795,477939-2924,2526,501
Cash from Investing2,3811,3924341,4791,464-2,702-705-263-258-1,381
Cash from Financing-753-272-1,469-2,871-1,000-4,871169474-3,836-5,230
7-52207-864863-29-81158-110

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.4854.4854.4854.4854.4854.4854.4854.4854.48
17.2318.0118.0517.9617.2616.5516.1215.9314.54
19.1718.4818.4318.5819.3820.1220.7221.0022.06
Government0.000.000.000.000.000.000.000.000.00
9.028.908.938.878.778.738.588.488.82

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
General Updates

2026-09-11 - Intimation under Regulation 30 of SEBI LODR

2026-09-09
General Updates

2026-09-09 - Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company

2026-09-08
Credit Rating- New

2026-09-08 - Sun Pharmaceutical Industries Limited has informed the Exchange about International Credit Ratings

2026-09-03
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-03 - Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

2026-09-01
Press Release

2026-09-01 - Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 01, 2026, titled "Sun Pharma Participates in White House Signing Ceremony Highlighting U.S. Medicines Pricing and Access Commitments".

2026-08-26
Copy of Newspaper Publication

2026-08-26 - Newspaper advertisements about Postal Ballot/E-Voting

2026-08-25
Shareholders meeting

2026-08-25 - Notice of Postal Ballot

2026-08-25
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

2026-08-17
General Updates

2026-08-17 - Update on Lipitor Antitrust Litigation

News

Recent coverage and analyst commentary for SUNPHARMA

Loading news…

🤖

AI Stock Analyst

Sun Pharmaceutical Industries Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login